{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"NCT 127, 정규 3집 리패키지 'Favorite' 선주문량 106만장 돌파","contents":"<a href=\"/news/news_read.naver?article_id=0004660936&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"NCT 127, 정규 3집 리패키지 'Favorite' 선주문량 106만장 돌파\">NCT 127, 정규 3집 리패키지 'Favorite' 선주문량 106만장 돌파</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004660936&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753552},{"title":"보령제약, 의사 맞춤형 의료정보채널 ‘브릿지’ 서비스 시작","contents":"<a href=\"/news/news_read.naver?article_id=0004620098&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"보령제약, 의사 맞춤형 의료정보채널 ‘브릿지’ 서비스 시작\">보령제약, 의사 맞춤형 의료정보채널 ‘브릿지’ 서비스 시작</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004620098&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753552},{"title":"라온피플, 브이씨와 25.5억원 골프센서 공급계약 \"매출 다변화로 실적개선\"","contents":"<a href=\"/news/news_read.naver?article_id=0004660912&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"라온피플, 브이씨와 25.5억원 골프센서 공급계약 &quot;매출 다변화로 실적개선&quot;\">라온피플, 브이씨와 25.5억원 골프센서 공급계약 \"매출 다변화로 실적개선\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004660912&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753573},{"title":"클리노믹스, 4세대 표적 폐암 치료제 개발사 ‘온코빅스’에 전략적 투자","contents":"<a href=\"/news/news_read.naver?article_id=0004728292&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"클리노믹스, 4세대 표적 폐암 치료제 개발사 ‘온코빅스’에 전략적 투자\">클리노믹스, 4세대 표적 폐암 치료제 개발사 ‘온코빅스’에 전략적 투자</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004728292&office_id=014&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753573},{"title":"KB운용, 해외부동산펀드 2조원 돌파···\"다양한 인력구성 강점\"","contents":"<a href=\"/news/news_read.naver?article_id=0003976961&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"KB운용, 해외부동산펀드 2조원 돌파···&quot;다양한 인력구성 강점&quot;\">KB운용, 해외부동산펀드 2조원 돌파···\"다양한 인력구성 강점\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003976961&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753573},{"title":"\"액티브ETF도 업계 1위\"···삼성운용, 액티브ETF 순자산 2,000억 돌파","contents":"<a href=\"/news/news_read.naver?article_id=0003976952&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211025&amp;page=1\" title=\"&quot;액티브ETF도 업계 1위&quot;···삼성운용, 액티브ETF 순자산 2,000억 돌파\">\"액티브ETF도 업계 1위\"···삼성운용, 액티브ETF 순자산 2,000억 돌파</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003976952&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211025&page=1","retrieved":1635126753573}]}